D
Galectin Therapeutics Inc. GALT
$5.70 $0.244.40% NASDAQ
Recommendation
Prev Close
$5.46
Volume
599,300
Avg Vol (90D)
324,828
Market Cap
$352.02M
Dividend & Yield
--
52-Week Range
$0.73 - $6.55
P/E (TTM)
--
EPS (TTM)
-$0.59
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Galectin Therapeutics (GALT, $5.46) entered Downtrend as Momentum indicator drops below 0 level on Dec 02, 2025
12/3/2025 - Tickeron - Stocks
Galectin Therapeutics (GALT, $5.73) Aroon Indicator entered an Uptrend on November 28, 2025.
11/29/2025 - Tickeron - Stocks
Galectin Therapeutics (GALT, $5.76) Aroon Indicator entered an Uptrend on November 26, 2025.
11/27/2025 - Tickeron - Stocks
Galectin Therapeutics (GALT, $5.76) entered Downtrend as Momentum indicator drops below 0 level on Nov 26, 2025
11/27/2025 - Tickeron - Stocks
Galectin Therapeutics (GALT, $5.71) Aroon Indicator entered an Uptrend on November 25, 2025.
11/26/2025 - Tickeron - Stocks
Galectin Therapeutics: NAVIGATE Data Validates The Fibrosis Thesis
11/26/2025 - Seeking Alpha - Long Ideas
Galectin Therapeutics: NAVIGATE Data Validates The Fibrosis Thesis
11/26/2025 - SeekingAlpha
Galectin Therapeutics (GALT, $5.51) Aroon Indicator entered an Uptrend on November 24, 2025.
11/25/2025 - Tickeron - Stocks
Wealthspire Advisors LLC Buys 81,144 Shares of Galectin Therapeutics Inc. $GALT
11/22/2025 - MarketBeat
Galectin Therapeutics (GALT, $5.35) Moving Average Convergence Divergence (MACD) Histogram turned negative on November 21, 2025
11/22/2025 - Tickeron - Stocks
Galectin Therapeutics (GALT, $5.35) Aroon Indicator entered an Uptrend on November 21, 2025.
11/22/2025 - Tickeron - Stocks
Galectin Therapeutics (GALT, $5.74) Aroon Indicator entered an Uptrend on November 20, 2025.
11/21/2025 - Tickeron - Stocks
Galectin Therapeutics (GALT, $6) Moving Average Convergence Divergence (MACD) Histogram turned positive on November 17, 2025
11/18/2025 - Tickeron - Stocks
Galectin Therapeutics (NASDAQ:GALT) Insider Sells 121,117 Shares
11/16/2025 - MarketBeat
Galectin Therapeutics (NASDAQ:GALT) Releases Earnings Results, Misses Estimates By $0.02 EPS
11/16/2025 - MarketBeat
Khurram Jamil Sells 121,117 Shares of Galectin Therapeutics (NASDAQ:GALT) Stock
11/15/2025 - MarketBeat
Galectin Therapeutics (NASDAQ:GALT) Stock Price Crosses Above Two Hundred Day Moving Average - Here's What Happened
11/15/2025 - MarketBeat
Galectin Therapeutics Reports Q3 2025 Financials
11/15/2025 - TipRanks Financial Blog
Galectin Therapeutics (GALT) Strengthens Belapectin's Profile with New Data
11/14/2025 - GuruFocus
Galectin Therapeutics reports Q4 EPS (13c) vs (18c) last year
11/14/2025 - The Fly
Galectin Therapeutics Reports Financial Results for the quarter ended September 30, 2025, and ...
11/14/2025 - GuruFocus
Galectin Therapeutics Reports Financial Results for the quarter ended September 30, 2025, and Provides Business Update
11/14/2025 - Globe Newswire
Galectin Therapeutics (GALT, $5.53) Aroon Indicator entered an Uptrend on November 13, 2025.
11/14/2025 - Tickeron - Stocks
Galectin Therapeutics (GALT, $5.83) Moving Average Convergence Divergence (MACD) Histogram turned positive on November 12, 2025
11/13/2025 - Tickeron - Stocks
Galectin Therapeutics (GALT, $5.83) Stochastic Oscillator left the oversold zone on November 12, 2025
11/13/2025 - Tickeron - Stocks
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
-$29.15M
Net Income (TTM)
-$37.30M
Balance Sheet
Total Assets (Q)
$12.87M
Total Debt (Q)
$126.05M
Total Liabilities (Q)
$136.45M
Book Value Per Share (Q)
-$1.95
Cash Flow
Cash from Operations (TTM)
-$30.62M
Cash from Investing (TTM)
--
Cash from Financing (TTM)
$15.09M
Net Change in Cash (TTM)
-$15.54M
Filings
Filing Date
Friday, November 14, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
End of March (est)
Price History
Loading...
Beta
-0.46
7-Day Total Return
6.54%
30-Day Total Return
7.55%
60-Day Total Return
15.15%
90-Day Total Return
86.27%
Year to Date Total Return
387.18%
1-Year Total Return
119.23%
2-Year Total Return
182.18%
3-Year Total Return
395.65%
5-Year Total Return
108.03%
52-week Low
Dec 20, 2024 - $0.73
52-week High
Sep 12, 2025 - $6.55
Valuation
Market Cap
$352.02M - Small Cap
Enterprise Value
$468.76M
Price/Sales (TTM)
--
Price/Book (Q)
-2.80
Dividends and Shares
Shares Outstanding
64.21
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
galectintherapeutics.com
Phone Number
678 620 3186
Address
4960 Peachtree Industrial Boulevard
Norcross, GA 30071
Country
United States
Year Founded
2000
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the drug research and development to create new therapies for fibrotic, cancer, and other diseases. Its lead... more
NASDAQ 12/03/2025 4:00PM Eastern Quotes delayed